GLP-1 drugs: what New Hampshire Medicaid paid

Q: Does a paid prescription mean New Hampshire Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

New Hampshire Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read New Hampshire Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What New Hampshire Medicaid’s payment record shows

In 2026Q1, the product New Hampshire Medicaid paid for most often was Ozempic®, at 1,800 prescriptions¹⁹ of the 3,290 to 3,434^{1,7,13,19,25,37} across all 8 products, or 55 percent of the published count.

New Hampshire Medicaid itself reimbursed at least $3,256,315 for these products in the quarter, about $995 per prescription. Pharmacies were paid $3,256,315 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,095.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what New Hampshire Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, New Hampshire Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What New Hampshire Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what New Hampshire Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 318¹	10%	$305,682	$305,682	$961
tirzepatideMounjaro®	Managed care	at least 785⁷	24%	$792,681	$792,681	$1,010
semaglutideWegovy®	Managed care	at least 307¹³	9%	$336,287	$336,287	$1,095
semaglutideOzempic®	Managed care	at least 1,800¹⁹	55%	$1,767,166	$1,767,166	$982
semaglutideRybelsus®	Managed care	at least 43²⁵	1%	$43,925	$43,925	$1,022
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Managed care	at least 21³⁷	<1%	$10,575	$10,575	$504
liraglutideliraglutide (generic)	Managed care	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through managed care, meaning a plan the program contracts with paid the pharmacy. This record shows no fee-for-service claims for these products. That is a fact about how the file reports, and it points at who to ask: the plan named on your card.

Against enrollment, that is 21.2 to 22.1 prescriptions per thousand people enrolled in New Hampshire Medicaid, on an average of 155,465 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 9 of the 168 product-quarters it holds a row for here, which is 5 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether New Hampshire Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what New Hampshire Medicaid paid for each product, quarter by quarter

Prescriptions New Hampshire Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®range 466 to 1,177	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld3 of 3 product codes withheld	at least 108 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$107,939 paid	at least 226 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$207,461 paid	466 paid prescriptions in the quarter (2024Q3)³Count$443,660 paid	813 paid prescriptions in the quarter (2024Q4)³Count$766,910 paid	1,177 paid prescriptions in the quarter (2025Q1)²Count$1,137,566 paid	at least 1,360 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$1,324,806 paid	at least 1,735 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$1,723,463 paid	at least 2,183 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$2,223,649 paid	at least 318 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$305,682 paid
tirzepatideMounjaro®range 431 to 872	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 13 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$8,511 paid	at least 60 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$43,307 paid	at least 92 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$74,922 paid	at least 127 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$119,303 paid	at least 184 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$170,614 paid	at least 192 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$172,808 paid	at least 295 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$263,294 paid	at least 351 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$328,158 paid	431 paid prescriptions in the quarter (2024Q4)⁹Count$424,498 paid	at least 537 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$510,503 paid	at least 671 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$645,343 paid	at least 767 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$737,958 paid	872 paid prescriptions in the quarter (2025Q4)⁸Count$844,846 paid	at least 785 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$792,681 paid
semaglutideWegovy®range 498 to 516	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	at least 48 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$54,433 paid	at least 64 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$73,989 paid	at least 42 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$51,025 paid	at least 59 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$72,425 paid	516 paid prescriptions in the quarter (2023Q1)¹⁶Count$628,026 paid	at least 736 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$893,567 paid	510 paid prescriptions in the quarter (2023Q3)¹⁶Count$630,519 paid	at least 449 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$548,690 paid	498 paid prescriptions in the quarter (2024Q1)¹⁵Count$625,346 paid	at least 1,142 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$1,410,878 paid	at least 1,952 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$2,418,761 paid	at least 2,574 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$3,164,958 paid	at least 2,973 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$3,675,959 paid	at least 3,325 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$4,193,851 paid	at least 3,540 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$4,506,446 paid	at least 3,123 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$3,976,756 paid	at least 307 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$336,287 paid
semaglutideOzempic®range 185 to 1,937	185 paid prescriptions in the quarter (2021Q1)²⁴Count$144,680 paid	at least 212 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$172,846 paid	at least 231 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$185,101 paid	at least 245 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$214,286 paid	at least 297 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$253,612 paid	at least 367 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$298,861 paid	at least 418 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$342,804 paid	at least 397 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$311,985 paid	at least 585 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$446,873 paid	at least 505 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$399,404 paid	at least 814 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$711,732 paid	at least 1,088 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$966,764 paid	at least 1,493 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$1,389,354 paid	1,937 paid prescriptions in the quarter (2024Q2)²¹Count$1,829,577 paid	at least 1,916 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$1,795,225 paid	at least 1,959 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$1,812,326 paid	at least 2,085 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$2,022,204 paid	at least 2,089 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$2,058,490 paid	at least 2,039 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$2,000,115 paid	at least 2,088 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$2,007,712 paid	at least 1,800 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$1,767,166 paid
semaglutideRybelsus®range 54 to 85	at least 12 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$8,546 paid	at least 13 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$12,886 paid	at least 12 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$11,280 paid	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁰Withheld7 of 7 product codes withheld	at least 31 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$23,120 paid	at least 41 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$30,157 paid	at least 65 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$46,288 paid	54 paid prescriptions in the quarter (2022Q4)²⁹Count$36,213 paid	81 paid prescriptions in the quarter (2023Q1)²⁸Count$61,487 paid	at least 80 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$63,980 paid	85 paid prescriptions in the quarter (2023Q3)²⁸Count$74,634 paid	61 paid prescriptions in the quarter (2023Q4)²⁸Count$51,044 paid	71 paid prescriptions in the quarter (2024Q1)²⁷Count$68,073 paid	85 paid prescriptions in the quarter (2024Q2)²⁷Count$82,878 paid	62 paid prescriptions in the quarter (2024Q3)²⁷Count$58,585 paid	at least 58 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$61,752 paid	68 paid prescriptions in the quarter (2025Q1)²⁶Count$72,808 paid	65 paid prescriptions in the quarter (2025Q2)²⁶Count$71,046 paid	at least 42 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$42,662 paid	at least 55 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$55,735 paid	at least 43 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$43,925 paid
liraglutideSaxenda®range 16 to 208	32 paid prescriptions in the quarter (2021Q1)³⁶Count$39,969 paid	57 paid prescriptions in the quarter (2021Q2)³⁶Count$71,905 paid	83 paid prescriptions in the quarter (2021Q3)³⁶Count$96,734 paid	117 paid prescriptions in the quarter (2021Q4)³⁶Count$132,819 paid	130 paid prescriptions in the quarter (2022Q1)³⁵Count$159,743 paid	128 paid prescriptions in the quarter (2022Q2)³⁵Count$156,366 paid	at least 185 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld³⁵At least$207,870 paid	at least 320 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld³⁵At least$360,238 paid	at least 310 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld³⁴At least$362,386 paid	at least 276 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld³⁴At least$309,878 paid	208 paid prescriptions in the quarter (2023Q3)³⁴Count$206,634 paid	57 paid prescriptions in the quarter (2023Q4)³⁴Count$74,297 paid	22 paid prescriptions in the quarter (2024Q1)³³Count$24,114 paid	68 paid prescriptions in the quarter (2024Q2)³³Count$80,270 paid	71 paid prescriptions in the quarter (2024Q3)³³Count$83,316 paid	88 paid prescriptions in the quarter (2024Q4)³³Count$97,506 paid	89 paid prescriptions in the quarter (2025Q1)³²Count$101,977 paid	94 paid prescriptions in the quarter (2025Q2)³²Count$103,657 paid	82 paid prescriptions in the quarter (2025Q3)³²Count$90,200 paid	16 paid prescriptions in the quarter (2025Q4)³²Count$15,591 paid	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 74 to 1,082	at least 821 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld⁴²At least$713,359 paid	at least 939 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld⁴²At least$826,915 paid	at least 1,018 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld⁴²At least$894,720 paid	1,054 paid prescriptions in the quarter (2021Q4)⁴²Count$932,463 paid	1,082 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,029,405 paid	1,070 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,006,497 paid	1,041 paid prescriptions in the quarter (2022Q3)⁴¹Count$967,835 paid	979 paid prescriptions in the quarter (2022Q4)⁴¹Count$892,600 paid	972 paid prescriptions in the quarter (2023Q1)⁴⁰Count$913,833 paid	780 paid prescriptions in the quarter (2023Q2)⁴⁰Count$746,449 paid	602 paid prescriptions in the quarter (2023Q3)⁴⁰Count$578,589 paid	506 paid prescriptions in the quarter (2023Q4)⁴⁰Count$478,315 paid	442 paid prescriptions in the quarter (2024Q1)³⁹Count$326,628 paid	313 paid prescriptions in the quarter (2024Q2)³⁹Count$224,573 paid	135 paid prescriptions in the quarter (2024Q3)³⁹Count$97,471 paid	74 paid prescriptions in the quarter (2024Q4)³⁹Count$51,878 paid	at least 13 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$9,051 paid	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	at least 21 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$10,575 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 72 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$46,168 paid	at least 141 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$90,576 paid	129 paid prescriptions in the quarter (2025Q1)⁴⁴Count$62,276 paid	at least 113 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$43,680 paid	at least 61 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$23,256 paid	at least 58 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$36,232 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld4 of 4 product codes withheld

What this page cannot tell you

Whether New Hampshire Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open New Hampshire in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, NH
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "81"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, NH
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "590"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, NH
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "238"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, NH
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, NH
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like ZEPBOUND%, state NH, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, NH
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like ZEPBOUND%, state NH, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, NH
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "181"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, NH
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "192"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, NH
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "88"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, NH
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "48"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, NH
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, NH
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like MOUNJARO%, state NH, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, NH
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "110"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, NH
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "1285"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, NH
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "632"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, NH
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "265"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, NH
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "45"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, NH
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, NH
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "757"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, NH
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "882"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, NH
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "918"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, NH
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "554"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, NH
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "233"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, NH
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "131"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, NH
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "31"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, NH
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "34"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, NH
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, NH
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "44"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, NH
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, NH
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, NH
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like SAXENDA%, state NH, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, NH
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "94"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, NH
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "88"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, NH
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "310"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, NH
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "320"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, NH
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "117"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, NH
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "21"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, NH
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, NH
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "290"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, NH
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "622"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, NH
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "698"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, NH
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "690"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, NH
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state NH, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NH", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, NH
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state NH, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "57"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, NH
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state NH, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "87"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, NH
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state NH, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like LIRAGLUTID%, state NH, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, NH
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state NH, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like LIRAGLUTID%, state NH, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, NH
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state NH, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NH", "product_name": "product_name like LIRAGLUTID%, state NH, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 41 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 7 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean New Hampshire Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.